The behavioral and emotional symptoms of Alzheimer's disease (AD) are frequently the most important clinical considerations for physicians, who can choose to employ behavioral/environmental (psychosocial) or psychopharmacologic measures to deal with such symptoms. The appropriate use of these modalities to treat behavioral/emotional symptoms isfacilitated by using a frame of reference that includes information as to where, when, and with whom symptoms occur, with what medication or medical condition, how often, and how troubling or dangerous to patient, caregiver; or others. It should also include patients' ability to communicate, learn and comprehend. This frame of reference can help clinicians appropriately balance their use of psychosocial and psychopharmacologic interventions with AD patients.
Get full access to this article
View all access options for this article.
References
1.
1. Davis KL, Thal LJ, Gamzu ER, et al: A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med1992;327:1253-1259
2.
2. Farlow M, Gracon SI, Hershey LA, et al: A controlled trial of tacrine in Alzheimerts disease. JAMA1992;268:2523-2529
3.
3. Brody EM, Kleban MH, Lawton MP, et al: Excess disabilities of mentally impaired aged: Impact of individual treatment. Gerontologist1971;11:124-133
4.
4. Cohen GD: One psychiatrist's view. In: Jarvik LF, Winograd CH, eds. Treatments for the Alzheimer Patient. New York: Springer Publishing, 1988, pp. 96-106
5.
5. Coccaro EF, Kramer E, Zemishlany Z, et al: Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am J Psychiatry1990;147:1640-1645
6.
6. Schneider LS, Pollack VE, Lyness SA: A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc1990;553-563
7.
7. Ray WA, Federspiel CF, Schaffner W.A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am J Public Health1980;70:485-491
8.
8. Beers M, Avorn J, Soumerai SB, et al. Psychoactive medication use in intermediate-care facility residents. JAMA1988; 260:3016-3020
9.
9. Health Care Financing Administration. Medicare and Medicaid: requirements for long term care facilities. Federal Register1991;56:48865-48921
11. Sim M, Sussman L. Alzheimer's disease: its natural history and differential diagnosis. J Nerv Ment Dis1962;135:489-499
12.
12. Liston E.The clinical phenomenology of presenile dementia: a critical review of the literature. J Nerv Ment Dis1979;167:329-336
13.
13. Rubin EH, Kinscherf DA. Psychopathology of very mild dementia of the Alzheimer type. Am J Psychiatry1989;146:1017-1021
14.
14. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer's isease. Am J Psychiatry1989;146:577-587
15.
15. Deutsch LH, Bylsma FW, Rovner BW, et al. Psychosis and physical aggression in Alzheimer's disease. Am J Psychiatry1991;148:1159-1163
16.
16. Bums A, Philpot M.Capgras' syndrome in a patient with dementia. Br J Psychiatry1987; 150:876-877
17.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, 1994. Washington, DC, American Psychiatric Press.
18.
18. Greenwald BS, Kramer-Ginsberg E, Marin DB, et al. Dementia with coexistent major depression. Am J Psychiatry1989; 146:1472-1478
19.
19. Bums A, Jacoby R, Levy R.Psychiatric phenomena in Alzheimer's disease. In: Disorders of thought content (72-76); II: Disorders of perception (76-8 1); III. Disorders of mood (81-86); IV: Disorders of behavior (86-94). Br J Psychiatry 1990;157:72-94
20.
20. Gold K, Rabins PV. Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation of six cases. Compr Psychiatry1989;30: 90-98
21.
21. Weiner MF. Dementia as a psychodynamic process. In: Weiner MF, ed. The Dementias: Diagnosis and Management. Washington DC, American Psychiatric Press, 1991: 29-46
22.
22. Chafetz PK. Structuring environments for dementia patients. In: Weiner MF, ed. The Dementias: Diagnosis and Management. Washington, DC: American Psychiatric Press, 1991:249-262
23.
23. Jones MK. Patient violence. Report of 200 incidents. J Psychosoc Nurs Ment Health Serv. 1985; 23:12-17
24.
24. Goldstein K.The Organism: A Holistic Approach to Biology Derived from Pathological Data in Man. New York, American Books, 1939
25.
25. Teri L, Logsdon RG. Identifying pleasant activities for Alzheimer's disease patients: The Pleasant Events Schedule-AD. Gerontologist1991;31:124-127
26.
26. Teri L, Uomoto, JM. Reducing excess disability in dementia patients: training caregivers to manage patient depression. Clin Gerontologist1991; 10:49-68
27.
27. Teri L.Non-pharmacological approaches to the management of patient behavion a focus on behavioral intervention for depression in dementia. In Gutman M, ed. Shelter and care of Persons with Dementia. Vancouver, BC, The Gerontology Research Center, Simon Frazer University, in press
28.
28. Teri L, Gallagher-Thompson D.Cognitive-behavioral interventions for treatment of depression in Alzheimer's patients. Gerontologist1991;31:413-416
